News

Avricore Health Welcomes Rodger Seccombe as New CEO

Avricore Health Welcomes Rodger Seccombe as New CEO

Rodger Seccombe Takes Leadership Role at Avricore Health

Avricore Health Inc. is thrilled to announce the appointment of Rodger Seccombe as the new CEO of the company. Having previously served as Chief Technology Officer (CTO) and co-founder of HealthTab™ Inc., a subsidiary under Avricore, Rodger brings a wealth of expertise and dedication to this leadership position.

Vision for the Future Under Seccombe's Leadership

David Hall, the Chairman of Avricore, expressed confidence in Rodger's capacity to steer the company toward its ambitious goals, particularly regarding the expansion of the HealthTab platform into new markets. As the former CTO, Rodger has been a pivotal figure in the development and deployment of this innovative technology that enhances health care accessibility. Under Rodger's leadership, Avricore is poised to accelerate its expansion plans, capitalizing on the growth potential in the UK and beyond.

Stepping Down: Hector Bremner's Contributions

As Rodger steps into his new role, it's important to acknowledge the significant contributions made by Hector Bremner, the outgoing CEO. Hector was instrumental in propelling Avricore's growth, particularly through successful partnerships with key players in the healthcare sector. His dedication and vision laid the foundation for the company's future advancements, and for that, he is sincerely appreciated.

HealthTab™: A Game-Changer in Community Health

One of Avricore's flagship offerings, HealthTab™, embodies the company's commitment to revolutionizing community health services. This point-of-care testing solution stands out as a leader in the industry, providing quick, lab-accurate results using just a few drops of blood. This innovative technology enables pharmacists to offer vital health information directly to patients, significantly enhancing the patient-care experience while fostering greater autonomy in managing health.

Innovative Features and Benefits of HealthTab™

HealthTab™ not only streamlines the testing process but also integrates a range of up to 23 critical biomarkers essential for monitoring chronic conditions such as diabetes and heart disease. Recently, Avricore has expanded HealthTab™ capabilities to include testing for various bacterial and viral infections, including strep and COVID-19. This versatility makes it an invaluable tool for healthcare providers and patients alike.

Avricore Health's Mission and Future Directions

Avricore Health Inc. is dedicated to advancing pharmacy practices through innovative technologies. The company’s strategic focus lies in enhancing patient care and ensuring that healthcare information is readily accessible. By establishing the largest network of rapid-testing solutions in community pharmacies, Avricore aims to elevate the standards of healthcare delivery. As the firm navigates through its transformative trajectory, it remains committed to reducing costs and waiting times, thus making healthcare more efficient and effective.

Forge Ahead: The Path Forward for Avricore

The company's future under Rodger Seccombe's leadership is centered on innovation and collaboration. Avricore seeks to engage with pharmacies and other healthcare stakeholders to optimize its public health programs. The expected outcomes will undoubtedly include increased revenue through various channels including equipment leasing, integrated programs for disease management, and research initiatives. This comprehensive approach encapsulates Avricore’s vision for a progressive health service model.

Frequently Asked Questions

Who is the new CEO of Avricore Health Inc.?

Rodger Seccombe has been appointed as the new CEO, transitioning from his previous role as CTO.

What is HealthTab™?

HealthTab™ is a point-of-care testing solution that provides rapid, lab-accurate results to patients using minimal samples of blood.

How does Avricore Health aim to improve healthcare delivery?

By focusing on innovative technologies like HealthTab™, Avricore Health seeks to make health information more accessible and enhance the role of pharmacists in primary care.

What was Hector Bremner's contribution to Avricore Health?

Hector Bremner played a crucial role as CEO and director, driving growth and partnerships that facilitated the company's expansion.

What are Avricore Health’s future plans?

Under Rodger Seccombe, Avricore plans to expand the HealthTab™ platform, enhance partnerships, and streamline healthcare delivery within community pharmacies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on Credit Trends in Canada with Holiday Impacts Ahead

Updated Category News Views 183

Trends in Consumer Credit Heading into the Holiday Season The holiday season often drives heightened consumer spending, and this year is no exception. However, recent trends in consumer credit have raised concerns, especially with Equifax Canada's latest report revealing some troubling statistics. Rising Delinquency and Its Implications The latest data from Equifax Canada...

Continue Reading
Innovative Collaboration Between Wharton Neuroscience and RMT

Updated Category News Views 88

Wharton Neuroscience and RMT: A Strategic Collaboration Wharton Neuroscience, recognized for its groundbreaking work in Neuroeconomics, has partnered with RMT, a cutting-edge AI-driven motivational analytics company. Together, they are launching an important advertising research project that aims to leverage the latest neuroscience insights for the benefit of global...

Continue Reading
Ongoing Investigation Into J.M. Smucker Co. Stockholder Rights

Updated Category News Views 153

Investigation of J.M. Smucker Company Bragar Eagel & Squire, P.C., known for its commitment to protecting stockholders' rights, is currently conducting an investigation into J.M. Smucker Company. The aim is to evaluate potential claims related to violations of federal securities laws and questionable business practices that may have impacted investors. What Should...

Continue Reading
Bybit Expands Horizons with Full License in Kazakhstan

Updated Category News Views 182

Bybit secured its full license from the Astana Financial Service Authority (AFSA) back in October 2024, making it a fully authorized player in Kazakhstan's cryptocurrency market. This wasn’t just a bureaucratic checkbox; it signified a strategic leap for Bybit as the second-largest cryptocurrency exchange by trading volume. With regulatory green lights flashing, traders...

Continue Reading
Innovative Partnership Enhances Correctional Education Systems

Updated Category News Views 112

Transforming Educational Access in Correctional Facilities In the modern educational landscape, partnerships are key in addressing the unique challenges faced by various sectors. One such significant collaboration is between Instructure and Orijin, which aims to enhance educational systems within correctional facilities throughout the country. This initiative is not...

Continue Reading